FDA Drug Recalls

Recalls / Class II

Class IID-0648-2023

Product

Microplegia (MSA/MSG 0.92 Molar) packaged in 125 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0001-1.

Affected lot / code info
Lot # 37-894942, Exp 05/01/2023; 37-896485, Exp 05/07/2023; 37-896793, Exp 05/08/2023; 37-898247, Exp 05/14/2023; 37-899149, Exp 05/19/2023; 37-900610, Exp 05/25/2023

Why it was recalled

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Recalling firm

Firm
Central Admixture Pharmacy Services, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6580 Snowdrift Rd Ste 100, N/A, Allentown, Pennsylvania 18106-9331

Distribution

Quantity
307 bags
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2023-04-28
FDA classified
2023-05-19
Posted by FDA
2023-05-31
Terminated
2025-06-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0648-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls